ATF4 and renal cell carcinoma: Taken together, our findings establish an intriguing mechanistic framework in which sorafenib induces ER stress in RCC cells, thereby activating the ATF4–CHOP axis, which in turn facilitates ferroptosis through dysregulation of ROS lipid metabolism.